Lv11
88 积分 2024-10-28 加入
Chemotherapy Treatment and Trials in Low-Grade Gliomas
6小时前
已完结
Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases
2个月前
已完结
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
4个月前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
4个月前
已完结
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
4个月前
已完结
The present and future of bispecific antibodies for cancer therapy
4个月前
已完结
Trastuzumab rezetecan, a new antibody–drug conjugate in HER2-mutated NSCLC
5个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
5个月前
已完结
Zenocutuzumab shows efficacy in NRG1 fusion-positive solid tumours
5个月前
已完结
Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers
5个月前
已完结
皖公网安备34019202002308
